risperidone has been researched along with Compensatory Hyperinsulinemia in 2 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The primary objective of this study was to evaluate insulin sensitivity in healthy subjects treated with olanzapine or risperidone." | 9.10 | Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. ( Breier, A; Carlson, C; Cavazzoni, P; Chinnapongse, S; Dananberg, J; Davis, T; Henry, RR; Mudaliar, S; Mukhopadhyay, N; Ray, A; Sowell, M, 2003) |
| "The primary objective of this study was to evaluate insulin sensitivity in healthy subjects treated with olanzapine or risperidone." | 5.10 | Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. ( Breier, A; Carlson, C; Cavazzoni, P; Chinnapongse, S; Dananberg, J; Davis, T; Henry, RR; Mudaliar, S; Mukhopadhyay, N; Ray, A; Sowell, M, 2003) |
| " To investigate the possible mechanisms of antipsychotic-induced metabolic effects, we studied the impact of chronic administration of a typical antipsychotic drug (haloperidol) and an atypical antipsychotic (risperidone) to male rats on food intake, body weight, adiposity, and the circulating concentrations of hormones and metabolites that can influence energy homeostasis." | 3.73 | Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats. ( Dedova, I; Duffy, L; Herzog, H; Karl, T; Lee, NJ; Lin, EJ; Matsumoto, I; O'brien, E; Sainsbury, A; Slack, K, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sowell, M | 1 |
| Mukhopadhyay, N | 1 |
| Cavazzoni, P | 1 |
| Carlson, C | 1 |
| Mudaliar, S | 1 |
| Chinnapongse, S | 1 |
| Ray, A | 1 |
| Davis, T | 1 |
| Breier, A | 1 |
| Henry, RR | 1 |
| Dananberg, J | 1 |
| Lin, EJ | 1 |
| Lee, NJ | 1 |
| Slack, K | 1 |
| Karl, T | 1 |
| Duffy, L | 1 |
| O'brien, E | 1 |
| Matsumoto, I | 1 |
| Dedova, I | 1 |
| Herzog, H | 1 |
| Sainsbury, A | 1 |
1 trial available for risperidone and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Blood Glucose; Body Weight; Fasting; Fatty Acids, None | 2003 |
1 other study available for risperidone and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats.
Topics: Adipose Tissue; Animals; Antipsychotic Agents; Appetite; Body Weight; Corticosterone; Diabetes Melli | 2006 |